Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes

Modern Pathology

Volumn 16, Issue 8, 2003, Pages 786-795

  Abraham, Susan C ^a   Park, Seun Ja ^b   Lee, Jae Hyuk ^b   Mugartegui, Lilian ^b   Wu, Tsung Teh ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

catenin; Adenoma; APC; K ras; Microsatellite instability; Stomach

Indexed keywords

APC PROTEIN; BETA CATENIN;

ADENOMA; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER GRADING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DYSPLASIA; FEMALE; GENE MUTATION; GOBLET CELL; HUMAN; HUMAN TISSUE; INTESTINE CELL; INTESTINE METAPLASIA; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; ONCOGENE K RAS; PANETH CELL; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH ADENOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH TUMOR;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BETA CATENIN; CYTOSKELETAL PROTEINS; FEMALE; GENES, RAS; HUMANS; INTESTINES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 0042389458     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000080349.37658.5E     Document Type: Article

References (51)

1. Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy 1994;26:659-65.
2. Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer 1994;74:2896-907.
3. Laxen F, Sipponen P, Ihamaki T, Hakkiluoto A, Dortscheva Z. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand [A] 1982;90:221-8.
4. Nakamura K, Sakaguchi H, Enjoji M. Depressed adenoma of the stomach. Cancer 1988;62:2197-202.
5. Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 1995;90:2152-9.
6. Sakurai S, Sano T, Nakajima T. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality. Pathol Int 1995;45:51-7.
7. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995;27:32-7.
8. Abraham SC, Montgomery EA, Singh VK, Yardley JH, Wu T-T. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002;26:1276-85.
9. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001;94:166-70.
10. Wang YZ, Mitomi H, Kurihara M, Ishihara K, Hotta K, Tanigawa H, et al. Gastric adenomas and superficial adenocarcinomas display distinct patterns of mucin carbohydrate and core protein expression. Histopathology 2000;37:250-9.
11. Kushima R, Muller W, Stolte M, Borchard F. Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch 1996;428:223-7.
12. Snover DC. Benign epithelial polyps of the stomach. Pathol Annu 1985;20 Pt 1:303-29.
13. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M, et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 1995;176:249-58.
14. Tamura G, Maesawa C, Suzuki Y, Tamada H, Satoh M, Ogasawara S, et al. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res 1994;54:1149-51.
15. Lee J-H, Abraham SC, Kim H-S, Nam J-H, Choi C, Lee M-C, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002;161:611-8.
16. Tsuchiya C, Ohshima S, Takahama M. Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials. J Gastroenterol 1997;32:28-33.
17. Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R, et al. Infrequent ras mutation in human stomach cancers. Jpn J Cancer Res 1993;84:163-7.
18. Isogaki J, Shinmura K, Yin W, Arai T, Koda K, Kimura T, et al. Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. Cancer Detect Prev 1999;23:204-14.
19. Oya M, Yao T, Tsuneyoshi M. Expressions of cell-cycle regulatory gene products in conventional gastric adenomas: possible immunohistochemical markers of malignant transformation. Hum Pathol 2000;31:279-87.
20. Kyokane K, Ito M, Sato Y, Ina K, Ando T, Kusugami K. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia. J Pathol 1998;184:382-9.
21. Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona RR. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 1993;88:1916-9.
22. Tohdo H, Yokozaki H, Haruma K, Kajiyama G, Tahara E. p53 gene mutations in gastric adenomas. Virchows Arch 1993;63:191-5.
23. Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, et al. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 1995;55:1933-6.
24. Nogueira AM, Carniero F, Seruca R, Cirnes L, Veiga I, Machado JC, et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer 1999;86:1649-56.
25. Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 2001;20:329-35.
26. Baek MJ, Kang H, Kim SI, Park JH, Lee JS, Paik YK, et al. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 2001;85:1147-52.
27. Kim HS, Woo DK, Bae SI, Kim YI, Kim WH. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 2000;80:57-64.
28. Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996;77:1620-7.
29. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol 1997;28:127-33.
30. Lauwers GY. Gastric dysplasia: diagnosis and significance. Pathol Case Rev 2002;7:27-34.
31. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia. The Padova international classification. Am J Surg Pathol 2000;24:167-76.
32. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997;150:1547-52.
33. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
34. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000;2:20-8.
35. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Terashima M, et al. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 1996;180:371-7.
36. Tamura G. Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach. Pathol Int 1996;46:834-41.
37. Offerhaus GJA, Giardiello FM, Krush A, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.
38. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Kato Y, et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 1992;52:3231-3.
39. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
40. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, et al. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999;96:1603-8.
41. Sellin JH, Umar S, Xiao J, Morris AP. Increased β-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 2001;61:2899-906.
42. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-4.
43. Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML. β-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999;59:1442-4.
44. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hausner P, et al. Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 1997;57:4478-81.
45. Tong JH, To KF, Ng EK, Lau JY, Lee TL, Lo KW, et al. Somatic β-catenin mutation in gastric carcinoma - an infrequent event that is not specific for microsatellite instability. Cancer Lett 2001;163:125-30.
46. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001;95:108-13.
47. Ebert MP, Fei G, Kahmann S, Muller O, Yu J, Sung JJ, et al. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002;23:87-91.
48. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K, et al. Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumour Biol 2001;22:123-30.
49. Candidus S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996;56:49-52.
50. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, et al. Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002;62:3503-6.
51. Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 2000;157:717-22.